Abstract
Paclitaxel (PTX), a microtubule-active agent, blocks cell proliferation by inhibiting mitotic progression leading to mitotic and postmitotic arrest and cell death. Here we demonstrate for the first time that very low concentrations of PTX (3–6 nM) can completely inhibit cell proliferation without arresting cells at mitosis. At these low concentrations that are insufficient to inhibit mitotic progression, PTX induced both p53 and p21 causing G1 and G2 arrest in A549. In contrast, low PTX concentrations failed to induce G1 and G2 arrest in A549/E6 cells, that do not express p53. Furthermore, we observed that the levels of p53 and p21 induced by adriamycin and by low concentrations of PTX in A549 cells were comparable. This observation led us to conclude that low concentrations of PTX can induce p53 and p21 sufficiently to cause G1 and G2. Many other cell lines, including HCT116 cells, do not readily upregulate p53 in response to PTX, and therefore undergo exclusively mitotic and postmitotic arrest after PTX treatment. At low concentrations that do not cause mitotic arrest, PTX did not significantly inhibit proliferation of these cells. In HCT116 cells, loss of p53 (HCT/p53−/−) or p21 (HCT/p21−/−) affects both Bax and Bcl-2 expression. In cells lacking p53, levels of Bax and p21 were decreased. In cells lacking p21, levels of wt p53 were highly increased to compensate for the loss of p21. This in turn results in upregulation of Bax and downregulation of Bcl-2 resulting in an increase of the apoptotic Bax/Bcl2 ratio consistent with increased sensitivity of these cells to apoptotic stimuli. High levels of p53 and Bax/Bcl-2 ratio can also explain why loss of p21 is rarely found in human cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
An WG, Hwang SG, Trepel JB, Blagosklonny MV . 2000 Leukemia 14: 1276–1283
Barboule N, Chadebech P, Baldin V, Vidal S, Valette A . 1997 Oncogene 15: 2867–2875
Bhalla K, Ibrado AM, Tourkina E, Tang C, Maloney ME, Huang Y . 1993 Leukemia 7: 563–568
Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R . 2001 Oncogene 20: 147–155
Blagosklonny MV . 1997 Oncogene 15: 1889–1893
Blagosklonny MV, Fojo T . 1999 Int. J. Cancer 83: 151–156
Blagosklonny MV, Robey R, Bates S, Fojo T . 2000 J. Clin. Invest. 105: 533–539
Blagosklonny MV, Schulte TW, Nguyen P, Mimnaugh EG, Trepel J, Neckers L . 1995 Cancer Res. 55: 4623–4626
Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B . 1998 Science 282: 1497–1501
Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Dutriaux A, Lengauer C, Kinzler KW, Vogelstein B . 1999 J. Clin. Invest. 104: 263–269
Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ . 1995 Science 267: 1353–1356
De Feudis P, Vignati S, Rossi C, Mincioni T, Giavazzi R, D'Incalci M, Broggini M . 2000 Neoplasia 2: 202–207
Debernardis D, Sire EG, De Feudis P, Vikhanskaya F, Valenti M, Russo P, Parodi S, D'Incalci M, Broggini M . 1997 Cancer Res. 57: 870–874
El-Deiry WS, Tokino T, Veculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825
Fan S, Cherney B, Reinhold W, Rucker K, O'Connor PM . 1998 Clin. Cancer Res. 4: 1047–1054
Friedlander P, Haupt Y, Prives C, Oren M . 1996 Mol. Cell. Biol. 16: 4961–4971
Fukasawa K, Choi T, Kuriyma R, Rulong S, Vande Woude GF . 1996 Science 271: 1744–1747
Gan Y, Wientjes MG, Schuller DE, Au JL . 1996 Cancer Res. 56: 2086–2093
Giannakakou P, Poy G, Zhan Z, Knutsen T, Blagosklonny MV, Fojo T . 2000a Oncogene 19: 3078–3085
Giannakakou P, Sackett DL, Ward Y, Blagosklonny MV, Fojo T . 2000b Nat Cell Biol 2: 709–717
Horwitz SB . 1992 Trends Pharmacol. Sci. 13: 134–136
Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L . 1996 Cancer Res. 56: 816–825
Jordan MA, Wilson L . 1998 Curr. Opin. Cell Biol. 10: 123–130
Khan SH, Wahl GM . 1998 Cancer Res. 58: 396–401
Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK . 2000 Clin. Cancer Res. 6: 1498–1507
Lane DP, Crawford LV . 1979 Nature 278: 261–263
Lanni JS, Jacks T . 1998 Mol. Cell. Biol. 18: 1055–1064
Li W, Fan J, Banerjee D, Bertino JR . 1999 Mol. Pharmacol. 55: 1088–1093
Linzer DI, Levine AJ . 1979 Cell 17: 43–52
Long BH, Fairchild CR . 1994 Cancer Res. 54: 4355–4361
Ludwig RL, Bates S, Vousden KH . 1996 Mol. Cell. Biol. 16: 4952–4960
Maurer BJ, Ihnat MA, Morgan C, Pullman J, O'Brien C, Johnson SW, Rasey JS, Cornwell MM . 1999 Mol. Pharmacol. 55: 938–947
Miyashita T, Reed JC . 1995 Cell 80: 293–299
Motwani M, Li XK, Schwartz GK . 2000 Clin. Cancer Res. 6: 924–932
Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G . 1998 Clin. Cancer Res. 4: 835–846
O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace AJJ, Kohn KW . 1997 Cancer Res. 57: 4285–4301
Rowinsky EK, Donehower RC . 1995 N. Engl. J. Med. 332: 1004–1014
Sablina AA, Chumakov PM, Levine AJ, Kopnin BP . 2001 Oncogene 20: 899–909
Safran H, King T, Choy H, Gollerkeri A, Kwakwa H, Lopez F, Cole B, Myers J, Tarpey J, Rosmarin A . 1996 Cancer 78: 1203–1210
Schmidt M, Lu Y, Liu BL, Fang M, Mendelsohn J, Fan Z . 2000 Oncogene 19: 2423–2429
Sionov RV, Haupt Y . 1999 Oncogene 18: 6145–6157
Stewart ZA, Mays D, Pietenpol JA . 1999 Cancer Res. 59: 3831–3837
Strobel T, Swanson L, Korsmeyer S, Cannistra SA . 1996 Proc. Natl. Acad. Sci. USA 93: 14094–14099
Thornborrow EC, Manfredi JJ . 1999 J. Biol. Chem. 274: 33747–33756
Torres K, Horwitz SB . 1998 Cancer Res. 58: 3620–3626
Trielli MO, Andreassen PR, Lacroix FB, Margolis RL . 1996 J. Cell. Biol. 135: 689–700
Vikhanskaya F, Vignati S, Beccaglia P, Ottoboni C, Russo P, D'Incalci M, Broggini M . 1998 Exp. Cell Res. 241: 96–101
Vogelstein B, Lane D, Levine AJ . 2000 Nature 408: 307–310
Vousden KH . 2000 Cell 103: 691–694
Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW, Galloway DA . 1996 Nature Med. 2: 72–79
Waldman T, Kinzler KW, Vogelstein B . 1995 Cancer Res. 55: 5187–5190
Woods CM, Zhu J, McQueney PA, Bollag D, Lazarides E . 1995 Mol. Med. 1: 506–526
Wu GS, El-Deiry WS . 1996 Nat Med. 2: 255–256
Yu DH, Jing T, Liu BL, Yao J, Tan M, McDonnell TJ, Hung MC . 1998 Mol. Cell 2: 581–591
Zaffaroni N, Silvestrini R, Orlandi L, Bearzatto A, Gornati D, Villa R . 1998 Br. J. Cancer 77: 1378–1385
Zeng S, Chen YZ, Fu LW, Johnson KR, Fan WM . 2000 Clin. Cancer Res. 6: 3766–3773
Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B . 2000 Science 290: 989–992
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giannakakou, P., Robey, R., Fojo, T. et al. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 20, 3806–3813 (2001). https://doi.org/10.1038/sj.onc.1204487
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204487
Keywords
This article is cited by
-
βcaryophyllene oxide induces apoptosis and inhibits proliferation of A549 lung cancer cells
Medical Oncology (2023)
-
Naringin and naringenin counteract taxol-induced liver injury in Wistar rats via suppression of oxidative stress, apoptosis and inflammation
Environmental Science and Pollution Research (2023)
-
Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines
Molecular Biology Reports (2022)
-
LY6K-AS lncRNA is a lung adenocarcinoma prognostic biomarker and regulator of mitotic progression
Oncogene (2021)
-
In-vivo antiproliferative activity of Morus latifolia leaf and bark extracts against Ehrlich’s ascites carcinoma
Toxicological Research (2020)